Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changing the Care Paradigm for Patients: Advanced Illness Beds Care Model.
Rimar A, Friedman MI, Quinteros MG, Gooch RA, Masick KD, DaCosta N, Spooner RL. Rimar A, et al. Among authors: dacosta n. Am J Hosp Palliat Care. 2021 Nov;38(11):1336-1341. doi: 10.1177/1049909120984384. Epub 2020 Dec 24. Am J Hosp Palliat Care. 2021. PMID: 33356792
Automated Identification of Patients with Advanced Illness.
Brar R, Friedman MI, Dacosta N, Rimar A, Cohen J, Liberman T, Hirsch JS, Bock K, Oppenheim M, Meytlis M. Brar R, et al. Among authors: dacosta n. AMIA Annu Symp Proc. 2023 Apr 29;2022:269-278. eCollection 2022. AMIA Annu Symp Proc. 2023. PMID: 37128398 Free PMC article.
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
Bardia A, Gucalp A, DaCosta N, Gabrail N, Danso M, Ali H, Blackwell KL, Carey LA, Eisner JR, Baskin-Bey ES, Traina TA. Bardia A, et al. Among authors: dacosta n. Breast Cancer Res Treat. 2018 Aug;171(1):111-120. doi: 10.1007/s10549-018-4813-z. Epub 2018 May 9. Breast Cancer Res Treat. 2018. PMID: 29744674 Free PMC article. Clinical Trial.
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Vahdat LT, Pruitt B, Fabian CJ, Rivera RR, Smith DA, Tan-Chiu E, Wright J, Tan AR, Dacosta NA, Chuang E, Smith J, O'Shaughnessy J, Shuster DE, Meneses NL, Chandrawansa K, Fang F, Cole PE, Ashworth S, Blum JL. Vahdat LT, et al. Among authors: dacosta na. J Clin Oncol. 2009 Jun 20;27(18):2954-61. doi: 10.1200/JCO.2008.17.7618. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349550 Clinical Trial.
27 results